Modern Healthcare News
 
RSS feed

Genetic testing news and information

News
Myriad Genetics still way ahead of burgeoning competition
By Jaimy Lee | August 12, 2014 | Basic Web Basic Web Subscription Details
Myriad Genetics, the Salt Lake City-based provider of diagnostic tests and lab services, said the company retained 92% of the lucrative laboratory testing market for the BRCA1 and BRCA2 genes during its most recent fiscal year.
FULL STORY »
 

Magazine
Soon-Shiong to head cancer care at Providence
By Modern Healthcare | August 09, 2014 | Print Magazine Print Magazine Subscription Details
Dr. Patrick Soon-Shiong, 62, will be global director for cancer services and bioinformatics at Providence Health & Services, Renton, Wash.
FULL STORY »
 

Information
New breast cancer risk pinpointed for women with mutation
By Bloomberg | August 07, 2014
Scientists have filled in another piece of the breast cancer puzzle with a finding that a mutated gene responsible for DNA repair raises the risk for women who carry it, suggesting it should be included in early testing.
FULL STORY »
 

News
FDA seeks more oversight of lab-developed diagnostic tests
By Steven Ross Johnson | August 04, 2014 | Basic Web Basic Web Subscription Details
The Food and Drug Administration's recently announced plan to begin regulating medical diagnostic laboratory testing is viewed by critics as an unnecessary step that could potentially stifle innovation in future testing models, but FDA supporters say such guidance has been long overdue.
FULL STORY »
 

Vital Signs
Macquarie analysis finds increased interest in DNA sequencing
By Darius Tahir | July 24, 2014
Healthcare organizations plan to ramp up their spending on DNA sequencing, though generally not on the sequencers themselves, according to a survey by Macquarie Research, the research arm of the investment bank Macquarie Group.
FULL STORY »
 


Advertisement | View Media Kit

Vital Signs
FDA: We like innovation. Just don't mess it up
By Darius Tahir | June 27, 2014
After an appearance before the U.S. House Energy & Commerce Committee, Dr. Jeffrey Shuren, director of the Food and Drug Administration's Center for Devices and Radiological Health, decided he should issue another communiqué clarifying his agency's position on innovation—this time on...
FULL STORY »
 

Information
As sequencing moves into clinical use, insurers balk
By Reuters | June 20, 2014
Once strictly the domain of research labs, gene-sequencing tests increasingly are being used to help understand the genetic causes of rare disease, putting insurance companies in the position of deciding whether to pay the $5,000 to $17,000 for the tests.
FULL STORY »
 

News
Genetic cancer screening moves beyond single-gene tests
By Jaimy Lee | May 22, 2014 | Basic Web Basic Web Subscription Details
Clinicians are ordering more comprehensive gene tests to look for mutations carrying higher risks of hereditary cancer.
FULL STORY »
 

News
Genome-analysis firm Omicia names Billings medical chief
By Rachel Landen | May 12, 2014 | Basic Web Basic Web Subscription Details
Dr. Paul Billings is the new chief medical officer of Omicia, an Oakland, Calif.-based company that provides genome analysis technology for research, diagnostic and clinical applications.
FULL STORY »
 

News
Myriad feels impact of Medicare reimbursement cuts
By Jaimy Lee | May 06, 2014 | Basic Web Basic Web Subscription Details
Myriad Genetics reported double-digit revenue growth in the third quarter even as sales in its oncology business dropped following cuts in Medicare reimbursement for hereditary breast and ovarian cancer testing.
FULL STORY »
 

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.